Lyophilized formulatons of engineered anti-IL-23p19 antibodies

Details for Australian Patent Application No. 2009288419 (hide)

Owner SCHERING CORPORATION

Inventors Li, Xuhong; Kashi, Ramesh S.; Badkar, Aniket

Agent Griffith Hack

Pub. Number AU-A-2009288419

PCT Pub. Number WO2010/027766

Priority 61/092,326 27.08.08 US

Filing date 25 August 2009

Wipo publication date 11 March 2010

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 9/19 (2006.01) Medicinal preparations characterised by special physical form - lyophilised

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

Event Publications

3 March 2011 PCT application entered the National Phase

  PCT publication WO2010/027766 Priority application(s): WO2010/027766

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009288425-System and method for detecting a camera

2009288413-Key device with movable key combination element and lock assembly